Select a State

Global health R&D delivers for Maryland

US government investment in global health R&D has delivered

$2.5 billion
to Maryland research institutions
30,700+ new jobs
for Maryland

Neglected diseases in Maryland

Chikungunya cases
86
Dengue cases
60
HIV diagnoses
13,396
Malaria cases
804
Tuberculosis cases
1,941
West Nile cases
177
Zika cases
142
--

Maryland's top USG-funded global health R&D institutions

National Institutes of Health (self-funding and other agency transfers)
$1.6 billion
Johns Hopkins University
$222.5 million
The Henry M. Jackson Foundation for the Advancement of Military Medicine
$221.9 million
U.S. Army Fort Detrick
$151.8 million
University of Maryland, Baltimore
$108.6 million
International Partnership for Microbicides
$44.7 million
Leidos Biomedical Research
$39.6 million
Westat Inc.
$28.5 million
Walter Reed Army Institute of Research (including Military HIV Research Program)
$17.8 million
Technical Resources International, Inc.
$17.7 million
US Naval Medical Research Center
$13.9 million
University of Maryland, College Park
$12.8 million
Biomedical Research Institute
$11.6 million
US Uniformed Services University of Health Sciences
$2.6 million
Armed Forces Research Institute of Medical Sciences
$2.1 million
EMMES Corporation
$1.8 million
University of Maryland Biotechnology Institute
$1.8 million
Aeras
$1.6 million
US Army Medical Research Institute of Infectious Diseases
$1.5 million
US Army Medical Research and Materiel Command
$796 thousand
NOVA Research Company
$436 thousand
Towson University
$411 thousand
LTC Corporation
$381 thousand
US Food and Drug Administration
$298 thousand

Maryland industry in global health R&D

Accelovance
Location(s):
Rockville
AstraZeneca
Location(s):
Frederick, Gaithersburg
Biological Mimetics
Location(s):
Frederick
Celgene
Location(s):
Odenton
Charles River Laboratories
Location(s):
Frederick, Germantown
Eisai
Location(s):
Baltimore
Emergent Biosolutions
Location(s):
Baltimore, Gaithersburg, Rockville
EMMES Corporation
Location(s):
Frederick, Rockville
Fyodor Bio
Location(s):
Baltimore
Genvec
Location(s):
Gaithersburg
GSK
Location(s):
Rockville
IDT Biologika
Location(s):
Rockville
Leadiant Biosciences
Location(s):
Gaithersburg
Leidos Biomedical Research
Location(s):
Bethesda, Fort Detrick, Frederick
LTS Corporation
Location(s):
Bethesda
NETE Solutions
Location(s):
Rockville
NOVA Research Company
Location(s):
Bethesda, Silver Spring
NovaVax
Location(s):
Gaithersburg
Sanofi
Location(s):
Bethesda
Prefectus BioSciences
Location(s):
Baltimore
Protein Potential
Location(s):
Rockville
Quigen
Location(s):
Frederick, Germantown
Sanaria
Location(s):
Rockville
Sequella Incorporated
Location(s):
Rockville
Sisu Global Health
Location(s):
Baltimore
SynPhaGen
Location(s):
Gaithersburg
Technical Resources International
Location(s):
Bethesda
Valneva
Location(s):
Gaithersburg
Westat
Location(s):
Rockville

Maryland's top areas of global health R&D by USG funding

60.6%
HIV/AIDS
7.0%
Malaria
14.9%
Tuberculosis
2.3%
Diarrheal diseases
9.3%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Leprosy
Trachoma
5.9%
Other
Bacteria pneumonia & meningitis
Cryptococcal meningitis
Ebola/viral hemorrhagic fevers
Salmonella infections
Rheumatic fever

Global health R&D at work in Maryland

The University of Maryland has developed a vaccine, Vaxchora™, to protect US adults traveling to cholera-affected areas. Vaxchora is the only cholera vaccine available in the United States, and the only single-dose vaccine for cholera licensed anywhere. Acquired through contaminated food or water, cholera can kill in less than 24 hours if left untreated. Widespread in 69 countries, this highly contagious disease impacts millions of people worldwide each year.

Footnotes